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We report the synthesis and genetic encoding of a recently discovered post-translational modiﬁcation, 2-hydroxyisobutyryl-lysine,
to the genetic code of E. coli. The production of homogeneous
proteins containing this amino acid will facilitate the study of
modiﬁcation in full-length proteins.

The number and complexity of identified lysine post-translational modifications (PTMs) continue to grow. Historically the
most commonly observed protein modifications are located at
lysine side chains, such as methylation or acetylation. In these
examples the charge state of a lysine side chain is altered,
which in turn can give rise to changes in interactions with
DNA and other biomolecules.1,2 This epigenetic control of
gene expression is vital, and malfunction of these systems can
be a hallmark of disease.3
In addition to acetylation and methylation, it has been
reported that lysine residues can be modified by malonylation,4 propionylation and butyrylation,5 succinylation,6 and
crotonylation.7 These modifications are derived from intracellular acyl-CoA metabolites and provide a wide spectrum of
epigenetic control of gene expression. The extent to which
these modifications are actively added and removed by
enzymes is a current interest in deciphering the “histone
code”. Recently proteomics profiling revealed a new lysine
modification that was identified as 2-hydroxyisobutyryl-lysine
(Khib) (1, Scheme 1).8 This modification appears to be conserved throughout evolution, appearing in human, mouse,
Drosophila, and yeast cells.8 Intriguingly, unlike other histone
marks which occur mainly at the N-terminus of histone proteins, Khib is seen distributed throughout the globular protein
structure, and includes many lysine residues that have not
been previously reported to be modified. Moreover, in comparison with other lysine PTMs, Khib is quite large and has the
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Scheme 1

Synthesis of Khib.

unique potential to serve as a hydrogen bond donor, raising
the possibility of significant structural changes and alternative
intermolecular interactions mediated by this modification. All
of these point to an important role in chromatin function.
Critical to the study of PTMs is the ability to produce pure
protein samples containing homogeneous compositions of a
modified residue. Lysine modifications in particular may oﬀer
the ability to generate a designer chromatin9 to study the
eﬀects of PTMs either individually or in concert. Modified
amino acids can be added to proteins using a combination of
peptide synthesis and expressed protein ligation.10 This
approach has the ability to precisely add PTMs, but it is technically challenging and cannot be scaled easily. As an alternative,
some amino acids containing PTMs have also been added to
the genetic codes of both prokaryotes and eukaryotes, allowing
biosynthetic production of target proteins containing sitespecific modifications. Indeed most lysine modifications
have been incorporated using the pyrrolysine translational
machinery.11–13 These in vivo production methods are very
adaptable to biochemical laboratories. Moreover, biosynthetic
production of proteins containing PTMs opens the door to
more sophisticated experiments such as phage display,14 incorporation of isotopic labels,15,16 and a wide variety of in vivo
experiments. Towards these goals we describe the synthesis
and addition of 2-hydroxyisobutyryl-lysine to the genetic code
of E. coli.
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Fig. 1 Production of sfGFP containing 1 at position 151. No protein is
produced in the absence of added unnatural amino acid.

The synthesis of Khib was performed from lysine by first preparing a copper complex, which allows for selective acylation
of the ε-nitrogen (Scheme 1). This complex was then treated
with 2-hydroxyisobutyryl-O-succinimide ester and the copper
was removed by a chelating agent to generate the final
product. This synthesis is simple and can provide gram-scale
quantities of amino acid for protein expression studies.
We decided to test whether Khib is a substrate for several
variants of the pyrrolysyl-tRNA synthetase (PylRS) derived from
either Methanosarcina barkeri (Mb) or Methanosarcina mazei
(Mm) (see the ESI†). These included the wild-type enzymes
and variants that have been shown to have relaxed substrate
specificity towards other, larger unnatural amino acids. The
screen utilized an expression plasmid for superfolder green
fluorescent protein (sfGFP) containing an amber stop codon,
TAG, in place of the codon for Y151. The plasmid also contains
the gene encoding the Mm-pyrrolysyl tRNA ( pylT). Incorporation of unnatural amino acid leads to the production of a fulllength protein and a corresponding increase in cellular fluorescence. Using a plate-based screening assay we first examined fluorescence in the presence and absence of Khib for any
observable diﬀerences. As a positive control, we also used
Nε-(tert-butyloxycarbonyl)-L-lysine (BocLys, (2), Scheme 1),
which is a known substrate for PylRS. Among the five variants
we screened the most observable fluorescence diﬀerence was
obtained using wild-type Mm PylRS. While the observable fluorescence was weak in comparison with BocLys, it did show
clear diﬀerences when compared to controls (see the ESI,

Fig. 2
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Fig. S2†). Variants with larger active sites did not appear to
accept Khib as the substrate.
We chose to perform medium-scale expression of sfGFP in
the presence and absence of 5 mM Khib and purified the resulting His-tagged proteins using Ni2+ aﬃnity chromatography. As
shown in Fig. 1, we observed robust protein expression
(∼10 mg L−1) only in the presence of Khib, indicating that this
amino acid can serve as a substrate, without further evolution
of PylRS. No protein is seen in the absence of Khib, verifying
that endogenous amino acids are not substrates for Mm PylRS.
In order to verify the position and identity of the mutation, a
gel slice of the produced protein was excised and subjected to
in-gel tryptic digest.17 Upon examining the tryptic fragments
by LC/MS/MS, the spectrum of the expected fragment was
trapped in a +2 charge state (Fig. 2). Fragment masses of this
ion are consistent with site-specific incorporation of Khib at the
correct position, in place of Y151. No masses that correspond
to the same fragment containing other natural amino acids at
position 151 were seen. In addition to tryptic peptide analysis,
the protein samples were analyzed by ESI-MS on intact protein
which also confirms incorporation of the amino acid (see the
ESI, Fig. S3†). Interestingly, we did not observe any masses
corresponding to a lysine residue at position 151 (or a resulting tryptic fragment), which would be indicative of active deacylation of Khib in E. coli. Removal of other lysine PTMs has
been previously observed and ascribed to bacterial sirtuins1312,
and can be prevented by the use of a nicotinamide enzyme
inhibitor. It is possible that Khib residues are not a substrate
for these enzymes at all or when in the context of this
mutation position in sfGFP.

Conclusions
In conclusion, we have demonstrated that the pyrrolysyl-tRNA
synthetase (PylRS) has a suitably relaxed substrate specificity
to accommodate 2-hydroxyisobutyryl-lysine (Khib). This,
coupled with a quick and high-yielding synthesis of this
important amino acid makes this technology accessible to
anyone working in the field of protein chemistry. We anticipate
that the ability to produce homogeneous samples of proteins
containing Khib will facilitate the study of the histone code and
chromatin function.

MS/MS spectrum of tryptic fragment of sfGFP bearing Khib at position 151.

6480 | Org. Biomol. Chem., 2015, 13, 6479–6481

This journal is © The Royal Society of Chemistry 2015

View Article Online

Organic & Biomolecular Chemistry

Communication

Acknowledgements

8 L. Dai, C. Peng, E. Montellier, Z. Lu, Y. Chen, H. Ishii,
A. Debernardi, T. Buchou, S. Rousseaux, F. Jin, B. R. Sabari,
Z. Deng, C. D. Allis, B. Ren, S. Khochbin and Y. Zhao, Nat.
Chem. Biol., 2014, 10, 365–370.
9 B. Fierz and T. W. Muir, Nat. Chem. Biol., 2012, 8, 417–
427.
10 T. W. Muir, D. Sondhi and P. A. Cole, Proc. Natl. Acad.
Sci. U. S. A., 1998, 95, 6705–6710.
11 B. J. Wilkins, L. E. Hahn, S. Heitmuller, H. Frauendorf,
O. Valerius, G. H. Braus and H. Neumann, ACS Chem. Biol.,
2015, 10, 939–944.
12 H. Neumann, S. Y. Peak-Chew and J. W. Chin, Nat. Chem.
Biol., 2008, 4, 232–234.
13 M. J. Gattner, M. Vrabel and T. Carell, Chem. Commun.,
2013, 49, 379–381.
14 F. Tian, M. L. Tsao and P. G. Schultz, J. Am. Chem. Soc.,
2004, 126, 15962–15963.
15 C. Castaneda, J. Liu, A. Chaturvedi, U. Nowicka, T. A. Cropp
and D. Fushman, J. Am. Chem. Soc., 2011, 133, 17855–
17868.
16 C. A. Castaneda, J. Liu, T. R. Kashyap, R. K. Singh,
D. Fushman and T. A. Cropp, Chem. Commun., 2011, 47,
2026–2028.
17 A. Shevchenko, H. Tomas, J. Havlis, J. V. Olsen and
M. Mann, Nat. Protocols, 2006, 1, 2856–2860.

This work was funded in part by NIH/NIGMS (GM084396).

Published on 07 May 2015. Downloaded by Virginia Commonwealth University on 03/12/2015 18:55:02.

Notes and references
1 P. Chi, C. D. Allis and G. G. Wang, Nat. Rev. Cancer, 2010,
10, 457–469.
2 C. T. Walsh, S. Garneau-Tsodikova and G. J. Gatto Jr.,
Angew. Chem., Int. Ed., 2005, 44, 7342–7372.
3 S. Timmermann, H. Lehrmann, A. Polesskaya and A. HarelBellan, Cell Mol. Life Sci., 2001, 58, 728–736.
4 Z. Xie, J. Dai, L. Dai, M. Tan, Z. Cheng, Y. Wu, J. D. Boeke
and Y. Zhao, Mol. Cell. Proteomics, 2012, 11, 100–107.
5 Y. Chen, R. Sprung, Y. Tang, H. Ball, B. Sangras, S. C. Kim,
J. R. Falck, J. Peng, W. Gu and Y. Zhao, Mol. Cell. Proteomics, 2007, 6, 812–819.
6 J. Park, Y. Chen, D. X. Tishkoﬀ, C. Peng, M. Tan, L. Dai,
Z. Xie, Y. Zhang, B. M. Zwaans, M. E. Skinner,
D. B. Lombard and Y. Zhao, Mol. Cell, 2013, 50, 919–930.
7 M. Tan, H. Luo, S. Lee, F. Jin, J. S. Yang, E. Montellier,
T. Buchou, Z. Cheng, S. Rousseaux, N. Rajagopal, Z. Lu,
Z. Ye, Q. Zhu, J. Wysocka, Y. Ye, S. Khochbin, B. Ren and
Y. Zhao, Cell, 2011, 146, 1016–1028.

This journal is © The Royal Society of Chemistry 2015

Org. Biomol. Chem., 2015, 13, 6479–6481 | 6481

